참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Pyridine | HCID 1049 | — |
| 반응물 | Phosgene | HCID 6371 | — |
| 반응물 | Diisopropylethylamine | HCID 81531 | — |
| 반응물 | 7-Bromo-2,3,4,5-tetrahydro-1,4-benzoxazepine hydrochloride | HCID 66820137 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | 7-bromo-2,3-dihydro-1,4-benzoxazepine-4(5H)-carbonyl chloride | HCID 86672020 | 101.7% |
반응 단계
7-bromo-2,3,4,5-tetrahydro-1,4-benzoxazepine hydrochloride (3.0 g, 11.34 mmol) was suspended in dichloromethane (30 mL) followed by addition of DIPEA (3 mL, 34 mmol) and pyridine (4 mL, 49 mmol) and the resulting partially heterogeneous mixture was added portionwise over 5 minutes to a 0° C. cooled solution of phosgene (20 W % in toluene, 15 mL, 28 mmol) in dichloromethane (15 mL). The resulting mixture was then allowed to slowly warm to room temperature over 30 minutes then concentrated. The residue was partitioned with ethyl acetate and water and the organic phase washed twice with 1M aqueous hydrochloric acid then brine, dried over anhydrous magnesium sulfate, filtered and concentrated to give 7-bromo-2,3-dihydro-1,4-benzoxazepine-4(5H)-carbonyl chloride (3.35 g) as a pale yellow oil. MS (EI) for C10H9BrClNO2: 292 (MH+).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08637499B2 |
|---|
| 출처 데이터셋 | uspto-grants-2014_01 |
|---|
| ORD ID | ord-28ce653894fe44dab97a9617993ac516 |
|---|
| 출처 메모 | uspto-grants-2014_01 |
|---|